The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Open accessAbstract
The mesolimbic dopaminergic system has been implicated in mediating the motivational effects of opioids and other drugs of abuse. The site of action of opioids within this system and the role of endogenous opioid peptides in modulating dopamine activity therein remain unknown. Employing the technique of in vivo microdialysis and the administration of highly selective opioid ligands, the present study demonstrates the existence of tonically active and functionally opposing mu and kappa opioid systems that regulate dopamine release in the nucleus accumbens, the major terminal area of A10 dopaminergic neurons. Thus, stimulation of mu-type receptors in the ventral tegmental area, the site of origin of A10 dopaminergic neurons, increases dopamine release whereas the selective blockade of this opioid receptor type results in a significant decrease in basal dopamine release. In contrast, stimulation of kappa-type receptors within the nucleus accumbens decreases dopamine release whereas their selective blockade markedly increases basal dopamine release. These data show that tonic activation of mu and kappa receptors is required for the maintenance of basal dopamine release in the nucleus accumbens. In view of the postulated role of the mesolimbic system in the mediation of drug-induced alterations in mood and affect, such findings may have implications for the treatment of opiate dependence and affective disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Anatomy of CNS opioid receptors
Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H., & Watson, S. J. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90093-8 · Cited by 1,194
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Self-citationMicrodialysis—Theory and application
Benveniste, H., & Hüttemeier, P. C. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90027-e · Cited by 646
Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
Ettenberg, A., Pettit, H. O., Bloom, F. E., & Koob, G. F. (1982) · Psychopharmacology · doi:10.1007/bf00428151 · Cited by 563
The mesolimbic dopamine system : from motivation to action
Willner, P., & Scheel‐Krüger, J. (1991) · Wiley eBooks · Cited by 561
Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04963.x · Cited by 539
Self-citationBinaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonists
Portoghese, P. S., Lipkowski, A. W., & Takemori, A. E. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90585-6 · Cited by 530
Bals-Kubik, R., Ableitner, A., Herz, A., & Shippenberg, T. S. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10296-6 · Cited by 524
Self-citationRossetti, Z. L., Hmaidan, Y., & Gessa, G. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90706-a · Cited by 521
Goldstein, A. (1976) · Science · doi:10.1126/science.959823 · Cited by 517
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Self-citationThe binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties
Magnan, J., Paterson, S. J., Tavani, A., & Kosterlitz, H. W. (1982) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00495865 · Cited by 509
Morphine-induced activation of A10 dopamine neurons in the rat
Gysling, K., & Wang, R. Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90913-7 · Cited by 491
The neuropharmacological basis of reward
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90364-c · Cited by 454
Evidence for two separate opiate peptide neuronal systems
WATSON, S. J., AKIL, H., RICHARD, C. W., & BARCHAS, J. D. (1978) · Nature · doi:10.1038/275226a0 · Cited by 414
Takemori, A. E., Ho, B. Y., Naeseth, J. S., & Portoghese, P. S. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21011-4 · Cited by 409
Kalivas, P. W., Widerlöv, E., Stanley, D., Breese, G., & Prange, A. J. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22000-6 · Cited by 358
Heroin reward is dependent on a dopaminergic substrate
Bozarth, M. A., & Wise, R. A. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90519-1 · Cited by 334
Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
Spyraki, C., Fibiger, H. C., & Phillips, A. G. (1983) · Psychopharmacology · doi:10.1007/bf00427827 · Cited by 307
Euphorigenic drugs: effects on the reward pathways of the brain.
Kornetsky, C. H., & Esposito, R. (1979) · PubMed · Cited by 297
Shippenberg, T. S., Bals-Kubik, R., & Herz, A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38109-7 · Cited by 274
Self-citationModulation of A10 dopamine neurons by gamma-aminobutyric acid agonists.
Kalivas, P. W., Duffy, P., & Eberhardt, H. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13057-7 · Cited by 267
Activation of hypothalamic β-endorphin pools by reward induced by highly palatable food
Dum, J. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90467-7 · Cited by 245
Endorphins in Mental Health Research
(1979) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-04015-5 · Cited by 225
Acquas, E., Carboni, E., Leone, P., & Di Chiara, G. (1989) · Psychopharmacology · doi:10.1007/bf00442800 · Cited by 207
Evidence that the aversive effects of opioid antagonists and ?-agonists are centrally mediated
Bals-Kubik, R., Herz, A., & Shippenberg, T. S. (1989) · Psychopharmacology · doi:10.1007/bf00444692 · Cited by 199
Self-citationAction of drugs of abuse on brain reward systems: An update with specific attention to opiates
Wise, R. A., & Bozarth, M. A. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90076-4 · Cited by 192
Stinus, L., Koob, G. F., Ling, N., Bloom, F. E., & Le Moal, M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.2323 · Cited by 182
Shippenberg, T. S., Bals-Kubik, R., & Herz, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91667-2 · Cited by 166
Self-citationHeijna, M. H., Padt, M., Hogenboom, F., Portoghese, P. S., Mulder, A. H., & Schoffelmeer, A. N. M. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90088-n · Cited by 159
The neurobiology of Drug and alcohol addiction
(1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90026-4 · Cited by 156
Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists
Shippenberg, T. S., & Herz, A. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90803-5 · Cited by 156
Self-citationProfound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats
Acquas, E., Carboni, E., & Chiara, G. D. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90214-b · Cited by 155
Non-competitive antagonists are potent activators of ventral tegmental A10 dopamine neurons
French, E. D., & Ceci, A. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90823-r · Cited by 152
Rewarding properties of β-endorphin as measured by conditioned place preference
Amalric, M., Cline, E. J., Martinez, J. L., Bloom, F. E., & Koob, G. F. (1987) · Psychopharmacology · doi:10.1007/bf00690919 · Cited by 125
Microdialysis measurement of in vivo neuropeptide release
Kendrick, K. M. (1990) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(90)90040-m · Cited by 118
Bals-Kubik, R., Shippenberg, T. S., & Herz, A. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90153-w · Cited by 109
Self-citationHawkins, K. N., Knapp, R. J., Lui, G. K., Gulya, K., Kazmierski, W., Wan, Y. P., Pelton, J. T., Hruby, V. J., & Yamamura, H. I. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23681-3 · Cited by 103
van Ree, J. M., Smyth, D. G., & Colpaert, F. C. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90170-x · Cited by 102
MORRIS, B. J., Millan, M. J., & Herz, A. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13426-5 · Cited by 100
Self-citationHakan, R. L., & Henriksen, S. J. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-10-03538.1989 · Cited by 91
Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94124-g · Cited by 81
Self-citationMolecular and Cellular Aspects of the Drug Addictions
D, A. G. M. (1989) · Springer eBooks · doi:10.1007/978-1-4613-8817-3 · Cited by 80
Stereospecific aversive property of narcotic antagonists in morphine-free rats
Stolerman, I. P., PILCHER, C. W. T., & D'Mello, G. D. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90628-8 · Cited by 79
Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists
Shippenberg, T. S., Bals-Kubik, R., Huber, A., & Herz, A. (1991) · Psychopharmacology · doi:10.1007/bf02244205 · Cited by 74
Self-citationInteraction between Endogenous Opioids and Dopamine within the Nucleus Accumbensa
Stinus, L., Cador, M., & Moal, M. L. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25972.x · Cited by 74
Petit, F., Hamon, M., Fournié‐Zaluski, M., Roques, B. P., & Glowinski, J. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90731-4 · Cited by 74
Marwah, J. (1987) · PubMed · Cited by 62
β-endorphin in brain limbic structures as neurochemical correlate of psychic dependence on drugs
Sweep, F. C. G. J., Wiegant, V. M., Vry, J. D., & van Ree, J. M. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90341-x · Cited by 61
Dilts, R. P., & Kalivas, P. W. (1990) · Synapse · doi:10.1002/syn.890060203 · Cited by 58
Osborne, P. G., O'Connor, W. T., & Ungerstedt, U. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08171.x · Cited by 55
Opioid peptides (endorphins) in pituitary and brain
D, A. G. M., & Cox, B. M. (1977) · Psychoneuroendocrinology · doi:10.1016/0306-4530(77)90027-0 · Cited by 55
Glimcher, P. W., Giovino, A. A., Margolin, D. H., & Hoebel, B. G. (1984) · Behavioral Neuroscience · doi:10.1037//0735-7044.98.2.262 · Cited by 52
Mucha, R., Millan, M., & Herz, A. (2004) · Psychopharmacology · doi:10.1007/bf00432214 · Cited by 47
Self-citationNeurochemical Aspects of Addiction: Opioids and Other Drugs of Abuse
Herz, A., & Shippenberg, T. S. (1989) · Springer eBooks · doi:10.1007/978-1-4613-8817-3_4 · Cited by 39
Self-citationDymshitz, J., & Lieblich, I. (1987) · Psychopharmacology · doi:10.1007/bf00176481 · Cited by 29
Dum, J., & Herz, A. (1987) · Interdisciplinary Science Reviews · doi:10.1179/isr.1987.12.2.180 · Cited by 21
Self-citationMotivational Effects of Opioids: Neurochemical and Neuroanatomical Substrates
Shippenberg, T. S., & Bals-Kubik, R. (1991) · Springer eBooks · doi:10.1007/978-3-642-46660-1_20 · Cited by 11
Self-citation
Cited by
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,346
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,181
Reward Processing by the Opioid System in the Brain
Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013
Metadata
- Authors
- Spanagel, R., Herz, A., & Shippenberg, T. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-03-15
- Volume
- 89
- Issue
- 6
- Pages
- 2046-2050
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2133672910
- Cited by
- 1,014
- References
- 62
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.